Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Angiogenesis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04885153
What this trial is testing

Effects of Oral Fenofibrate on Retinal Thickness and Macular Volume

Who this might be right for
Diabetic RetinopathyDyslipidemiasDiabetes Mellitus
Universitas Indonesia 36
Not applicableNot Yet RecruitingNCT06858956
What this trial is testing

Real-World Study of Chidamide Combined With PD-(L)1 Inhibitors and Anti-Angiogenic Therapy for Advanced MSS-Type Colorectal Cancer

Who this might be right for
Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 200
Testing effectiveness (Phase 2)Study completedNCT00768937
What this trial is testing

Sorafenib and Transarterial Chemoembolization for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Medical University of Vienna 22
Not applicableUnknownNCT02903043
What this trial is testing

Expression of miR-204 and Consequences on Capillarization in Limb Muscles of Patients With COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
Laval University 100
Not applicableWithdrawnNCT00900081
What this trial is testing

Cyclooxygenase-2 Expression in Tissue Samples From Patients With a Normal Cervix, Cervical Intraepithelial Neoplasia, or Early Invasive Cervical Cancer

Who this might be right for
Cervical CancerPrecancerous Condition
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Ended earlyNCT01705392
What this trial is testing

Bevacizumab vs Dacarbazine in Metastatic Melanoma

Who this might be right for
Metastatic Malignant MelanomaUnresectable Malignant Melanoma
Haukeland University Hospital 2
Testing effectiveness (Phase 2)Ended earlyNCT00476827
What this trial is testing

A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain

Who this might be right for
Breast Cancer
Duke University 16
Testing effectiveness (Phase 2)Study completedNCT04172571
What this trial is testing

The Combination of Anti-PD-1 AK105 and Anlotinib in First-line Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Akeso 31
Testing effectiveness (Phase 2)Study completedNCT00026975
What this trial is testing

Efficacy of Hyperbaric Oxygen Therapy in Laryngectomy Patients

Who this might be right for
Laryngeal Cancer
National Center for Complementary and Integrative Health (NCCIH) 150
Testing effectiveness (Phase 2)Ended earlyNCT01067989
What this trial is testing

Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer

Who this might be right for
ChemotherapyBreast Cancer, Metastatic
HaEmek Medical Center, Israel 22
Testing effectiveness (Phase 2)Ended earlyNCT01215578
What this trial is testing

Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine Tumors

Who this might be right for
Neuroendocrine TumorsPancreatic NeoplasmsAdvanced Disease+1 more
Assistance Publique - Hôpitaux de Paris 33
Testing effectiveness (Phase 2)Study completedNCT01553188
What this trial is testing

AMG 386 and Abiraterone for Advanced Prostate Cancer

Who this might be right for
Prostatic NeoplasmsProstate CancerNeoplasm, Prostate+1 more
National Cancer Institute (NCI) 36
Not applicableStudy completedNCT00842790
What this trial is testing

Impact of Predicting Anti-angiogenic Response in mRCC Using Functional Imaging

Who this might be right for
Carcinoma, Renal Cell
Assistance Publique - Hôpitaux de Paris 107
Early research (Phase 1)Study completedNCT01251926
What this trial is testing

EZN-2208 (Pegylated SN-38) in Combination With Bevacizumab in Refractory Solid Tumors

Who this might be right for
Neoplasms
National Cancer Institute (NCI) 12
Large-scale testing (Phase 3)Ended earlyNCT01009593
What this trial is testing

Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma Non-resectableHepatocellular Carcinoma RecurrentCarcinoma, Hepatocellular+10 more
Abbott 1,035
Testing effectiveness (Phase 2)Looking for participantsNCT07443826
What this trial is testing

CALM-AF-AI: Counteracting Age-related Loss of Muscle With AAV-Follistatin Combined With Angiogenesis-Inducing VEGF Plasmid Gene Therapy

Who this might be right for
Age-related Muscle Decline
Unlimited Biotechnology LLC 12
Testing effectiveness (Phase 2)Study completedNCT01639248
What this trial is testing

Phase 2 Study - Aurora + Angiogenic Kinase Inhibitor ENMD-2076 in Previously Treated Locally Advanced + Metastatic TNBC

Who this might be right for
Triple Negative Breast Cancer
CASI pharmaceuticals, Inc. 41
Testing effectiveness (Phase 2)Study completedNCT00016549
What this trial is testing

Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Study completedNCT00176748
What this trial is testing

Treatment for Patients With Metastatic Thyroid Cancer

Who this might be right for
Thyroid Cancer
University of Michigan Rogel Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT00076011
What this trial is testing

Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Kidney Neoplasms
Pfizer 52
Next Page